Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · IEX Real-Time Price · USD
6.56
-0.43 (-6.15%)
Apr 25, 2024, 4:00 PM EDT - Market closed
RANI Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for RANI stock have an average target of 11.5, with a low estimate of 8.00 and a high estimate of 17. The average target predicts an increase of 75.30% from the current stock price of 6.56.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 27, 2024.
Analyst Ratings
The average analyst rating for RANI stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $21 → $9 | Strong Buy | Maintains | $21 → $9 | +37.20% | Mar 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +82.93% | Mar 25, 2024 |
| Wedbush | Wedbush | Buy Reiterates $8 | Buy | Reiterates | $8 | +21.95% | Feb 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $16 | Strong Buy | Maintains | $20 → $16 | +143.90% | Nov 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +204.88% | Sep 20, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.84
from -1.33
EPS Next Year
-0.67
from -0.84
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 31.7M | 149.2M | 584.1M |
| Avg | n/a | n/a | 19.4M | 80.2M | 275.9M |
| Low | n/a | n/a | n/a | 32.5M | 147.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 667.3% | 628.7% |
| Avg | - | - | - | 312.2% | 244.2% |
| Low | - | - | - | 67.2% | 83.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.61 | -0.48 | -0.45 | 0.41 | 2.69 |
| Avg | -0.84 | -0.67 | -0.48 | 0.15 | 1.56 |
| Low | -0.98 | -0.80 | -0.50 | -0.09 | 0.48 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 1,656.9% |
| Avg | - | - | - | - | 916.7% |
| Low | - | - | - | - | 213.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.